• Home
  • Stock
  • Glaxosmithkline Pharmaceuticals Fundamental Analysis
  • Glaxosmithkline Pharmaceuticals Fundamental Analysis

Glaxosmithkline Pharmaceuticals fundamental analysis

GLAXO

HealthcareLarge

2556.5

45.70 (1.82%)
Last updated on 6 Dec, 2025 | 14:02 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Glaxosmithkline Pharmaceuticals Fundamentals

P/E Ratio

45.1

P/B Ratio

25.23

Div. Yield

2.12

Sector P/E

36.18

Sector P/B

0.98

Sec. Div. Yield

0.56

  • Glaxosmithkline Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 45.1, compared to the sector average of 36.18. Its P/B Ratio stands at 25.23, while the sector’s is 0.98. In terms of returns, the stock offers a Dividend Yield of 2.12%, which is than the sector’s 0.56%.

Glaxosmithkline Pharmaceuticals Score Card

  • Price

    Attractive

  • Growth

    Poor

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Glaxosmithkline Pharmaceuticals reflects: Price – Attractive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.